Guglielmo Lentini

Dr. Guglielmo Lentini

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2025 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
GLGuglielmo Lentini
Guglielmo Lentini
AQAlessandro Querqui
Alessandro Querqui
NMNoemi Monti
Noemi Monti
Mariano BizzarriMariano Bizzarri
Mariano Bizzarri
Introduction: This Expert Opinion covers recent updates in the use of Inositol in polycystic ovary syndrome (PCOS), highlighting the specific effects triggered upon ovarian steroidogenesis. Areas Covered: An impressive body of evidence, obtained from molecular, animal and clinical studies, demonstrated the striking association between PCOS and the metabolism of myo-Inositol (myo-Ins) and its isomer D-Chiro-Inositol (DCI). Early investigations focused primarily on the metabolic consequences of inositol in modulating insulin transduction. However, recent advances disclosed that Inositols trigger direct effects on steroidogenesis. High DCI levels exacerbate androgen synthesis, and downregulate aromatase expression. Myo-Ins modulates insulin effects too, but exerts opposite actions on steroidogenesis, by increasing aromatase and FSH receptor expression. Clinical studies demonstrated myo-Ins efficacy, suggesting that an appropriate ratio in between myo-Ins/DCI (40:1) improves the reproductive function in PCOS women, even in absence of insulin resistance. Expert Opinion: Inositol-based treatments in PCOS are gaining momentum, demonstrating safety and efficacy greater than those obtained with other pharmacological agents. The efficacy depends not only on the modulation of insulin sensitivity but also on the direct, steroidogenic effects upon the ovaries. Adequate adsorption of Inositol is a critical issue, and the association of α-Lactalbumin can significantly overcome this problem. However, if a treatment based on inositol could be equally effective on different phenotypes of PCOS needs a specific assessment. Plain Language Summary: Myo-inositol (myo-Ins) and D-chiro-inositol (DCI) are two isomers of inositol playing a key role in insulin signaling throughout the body, mainly through their phosphoglycan derivatives. They act as important regulators of hormone production within the ovaries, modulating steroidogenesis.Molecular and clinical studies showed that myo-Ins enhances FSH and aromatase activity, while DCI stimulates androgenesis in the theca. These isomers seem to have opposite, yet complementary, actions upon ovarian function. In the last decades, inositols have emerged to treat Polycystic Ovary Syndrome (PCOS), one of the most common benign ovarian disorders affecting young, fertile women.Myo-Ins/DCI ratio in the blood averages 40:1, and this parameter has been used as a basis for establishing a pharmacological formula. Treatments based according to this ratio showed to be successful in the management of several symptoms and signs of PCOS. This is particularly evident in obese patients, whereby the low doses of DCI help in counteracting insulin resistance.Further extensive research, both at the molecular and clinical levels, is needed to better understand inositol biology in mammals. In particular, it should be clarified how myo-inositol modulates the nuclear steroidogenic factor-1 (SF-1) and other key enzymes involved in steroid production. This could be done through epigenetic modifications.

20 March 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
GLGuglielmo Lentini
Guglielmo Lentini
AQAlessandro Querqui
Alessandro Querqui
Alessandro GiulianiAlessandro Giuliani
Alessandro Giuliani
Roberto VernaRoberto Verna
Roberto Verna
Mariano BizzarriMariano Bizzarri
Mariano Bizzarri
Plasma membrane plays a pivotal role in orchestrating motility and invasive processes, as well as mitosis and genome expression. Indeed, specialized regions of the plasma membrane enriched in phosphoinositides—namely PIP2 and PIP3—can accommodate the requirements of the dynamic interface, which mediates the interplay between cells and their microenvironment. The fine-tuned balance between the two phosphoinositides is instrumental in regulating cytoskeleton organization, motility, ion channel activation, and membrane traffic. The balanced expression of PIP2/PIP3 fulfills these functions by activating pathways through several transporter and receptor proteins. These dynamic interactions modulate the interplay with the extracellular environment by decreasing/increasing their exposure on the cell surface. In this way, lipid structures can rapidly either dismiss or recruit specific proteins, eventually favoring their cooperation with membrane receptors and ion channels. Particularly, exposure of proteins can be managed through the internalization of plasma membrane segments, while receptor signaling can be desensitized by their removal from the cell surface. Notably, the equilibrium between PIP2 and PIP3 is largely dependent on inositol availability, as inositol addition enhances PIP2 content while reducing PIP3 via PI3K inhibition. Pharmacological modulation of PIP2/PIP3 balance promises to be an interesting target in different clinical settings.

Verified
Journal Article
Open access
PDF file
NMNoemi Monti
Noemi Monti
DADaniele Antinori
Daniele Antinori
SPSara Proietti
Sara Proietti
APAurora Piombarolo
Aurora Piombarolo
AQAlessandro Querqui
Alessandro Querqui
Mariano BizzarriMariano Bizzarri
Mariano Bizzarri
Herein, we demonstrate that soluble factors extracted from the distinct phases of the development of zebrafish embryos (ZFEs) exhibit a specific miRNA profile. We removed proteins and concentrated miRNAs in different phase-related samples, which we investigated further. We observed that ZFEs modulate miRNA expression in both normal and cancerous breast cells, significantly inhibiting the invasiveness and motility of triple-negative breast cancer cells. Namely, ZFEs reactivate the synthesis of miR-218-5p in cancerous cells, leading to the downregulation of PI3K, which consequently alters the distribution of phosphoinositides (such as PIP2/PIP3). Moreover, the silencing of miR-218-5p abolished the ZFE effects. Restoring a proper PIP2/PIP3 ratio is crucial for promoting the regression of the malignant phenotype. Phenotypic reversion follows the extensive cytoskeleton rearrangement and the re-emergence of E-cadherin/β-catenin complexes. In addition, ZFEs antagonize the Epithelial Mesenchymal Transition (EMT) by modulating several pathways, including the TCTP-p53 axis. Overall, these results show that embryo extracts enriched with fish miRNAs reactivate endogenous miR-218-5p in cancerous cells, which in turn downregulates critical pathways involved in tumor progression and metastasis.

7 September 2026 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
PDF file
EGE. Galante
E. Galante
MBM. Bizzarri
M. Bizzarri
NMN. Monti
N. Monti
GLGuglielmo Lentini
Guglielmo Lentini
The Wound Healing Assay is a standard technique for studying cell motility, yet it faces challenges in reproducibility and data interpretation. Here we present WoundPy, a Python-based executable software featuring a user-friendly interface for semi-automatic, researcher-supervised Region of Interest detection. WoundPy streamlines image analysis and management of replicates, providing rapid graphical outputs. A key pre-processing feature is the automated vertical wound alignment, which eliminates operator-dependent errors typical of optical microscopy. Velocity results are calculated as absolute values from multi-time-point imaging. The software was tested on three datasets from biological experiments, and a comparison with ImageJ Wound Healing Size tool revealed a significant underestimation of the wound area by the latter compared to WoundPy. In conclusion, this new software offers an extremely streamlined approach that easily enables to perform an analysis that is both accurate and fast, drastically reducing the time required for both numerical data acquisition and its subsequent analysis.